| Urology Associates of North Texas |
|
|
|
 |
| Harrison M. Abrahams, M.D. |
 |
|
|
| Lawrence J. Alter, MD |
 |
|
|
| Aaron Amos, MD |
 |
|
|
| Jeffrey Charles Applewhite, MD |
 |
|
|
| Gordon S. Brody, MD |
 |
|
|
| Tracy W Cannon-Smith, MD |
 |
|
|
| Paul Chan, MD |
 |
|
|
| Weber W Chuang, MD |
 |
|
|
| Patrick Collini, MD |
 |
|
|
| Kevin D Diamond, MD |
 |
|
|
| Robert A. Dowling, MD |
 |
|
|
| David S. Ellis, MD |
 |
|
|
| Patrick R. Frey, MD |
 |
|
|
| Carl I. Frisina, MD |
 |
|
|
| Alex Gordon, MD |
 |
|
|
| Michael B. Gruber, MD, PA |
 |
|
|
| Melanie Haluszka, MD |
 |
|
|
| Pat Hezmall, MD |
 |
|
|
| Ira N. Hollander, MD |
 |
|
|
| John M. House, MD |
 |
|
|
| John Jaderlund, MD |
 |
|
|
| James Daniel Johnson, MD |
 |
|
|
| E. Paul Kaplan, MD |
 |
|
|
| Justin Lee, MD |
 |
|
|
| Kenneth Licker, MD |
 |
|
|
| Wade L. Lowry, MD |
 |
|
|
| Barney T Maddox, MD |
 |
|
|
| Mark McCurdy, MD |
 |
|
|
| Leslie McQuiston, MD |
 |
|
|
| F.H. (Trey) Moore, III, MD |
 |
|
|
| Mark A. Norris, MD, PA |
 |
|
|
| Urology Associates of North Texas |
 |
|
|
| Chris Pace, MD |
 |
|
|
| Kirk Pinto, MD |
 |
|
|
| Gary Price, MD |
 |
|
|
| Jeff L Pugach |
 |
|
|
| Delbert C. Rudy, MD |
 |
|
|
| James Saalfield, MD |
 |
|
|
| Richard Scriven, MD |
 |
|
|
| David Shepherd, MD |
 |
|
|
| Ali Shirvani, MD |
 |
|
|
| Marie-Blanche Tchetgen, MD |
 |
|
|
| A. E. Thurman, MD |
 |
|
|
| Scott A. Thurman, MD |
 |
|
|
| Thomas C. Truelson, MD |
 |
|
|
| James C. Vestal, MD |
 |
|
|
| Keith A Waguespack, MD |
 |
|
|
| Diane West, MD |
 |
|
|
|
|
Prostate-Specific Antigen (PSA) |
 |
|
In This Article
| |
A prostate-specific antigen (PSA) test measures the amount of
in the blood. PSA is
released into a man's blood by his
. Healthy men have low amounts of PSA in
the blood. The amount of PSA in the blood normally increases as a man's
enlarges with age. PSA may increase as a
result of an injury, a digital rectal exam, sexual activity (ejaculation),
inflammation of the prostate gland (),
or
. Prostate cancer often
grows very slowly, without causing major problems. Detecting prostate cancer
early and treating it may prevent some health problems and reduce the risk of
dying from the cancer. However, some treatments for prostate cancer can cause
other problems, such as controlling urination ()
or erection problems (). Some men may
choose not to have a PSA test or treat prostate cancer if it is detected. For
example, a man older than age 75 who has no bothersome symptoms of prostate
cancer may choose not to treat the cancer if it is found, so he would not need
a PSA test. Should I have a prostate-specific antigen (PSA) test to screen for prostate cancer?

Health Tools help you make wise health decisions or take action to improve your health. 
The prostate-specific antigen (PSA) test
is done to: - Watch prostate cancer and see if treatment is
working. If PSA levels increase, the cancer may be growing or spreading. PSA is
usually not present in a man who has had his prostate gland removed. A PSA
level that rises after prostate removal may mean the cancer has returned or has
spread.
- Check if cancer may be present when results from other
tests, such as a
, are not normal. A PSA test does
not diagnose cancer, but it can be used along with other tests to determine if
cancer is present.
- Check men for prostate cancer. Experts disagree
on the usefulness of PSA testing as a screening tool for prostate cancer. If a
PSA test is used for screening, it is usually done for men older than age 50 or
for those at high risk for prostate cancer, such as men with a family history
of prostate cancer, or for African-American men who have a higher chance of
developing cancer than other men. Since other common medical conditions, such
as prostatitis, can cause high PSA levels, a prostate
is needed to confirm a diagnosis of cancer.

Before you have a prostate-specific
antigen (PSA), tell your doctor if you have had a: - Test to look at your bladder () in the past several
weeks.
- Prostate needle biopsy in the past several weeks.
- Prostate infection (prostatitis) or an
that has not gone
away.
- Tube () inserted into your bladder to
drain urine recently.
Do not ejaculate during the 2 days before your PSA blood
test, either during sex or masturbation. Talk to your doctor about
any concerns you have regarding the need for the test, its risks, how it will
be done, or what the results will indicate. To help you understand the
importance of this test, fill out the
(What is a document?)
. 
The health professional taking a sample
of your blood will: - Wrap an elastic band around your upper arm to
stop the flow of blood. This makes the veins below the band larger so it is
easier to put a needle into the vein.
- Clean the needle site with
alcohol.
- Put the needle into the vein. More than one needle stick
may be needed.
- Attach a tube to the needle to fill it with
blood.
- Remove the band from your arm when enough blood is
collected.
- Put a gauze pad or cotton ball over the needle site as
the needle is removed.
- Put pressure to the site and then a
bandage.

The blood sample is taken from a vein in
your arm. An elastic band is wrapped around your upper arm. It may feel tight.
You may feel nothing at all from the needle, or you may feel a quick sting or
pinch. 
There is very little chance of a problem from
having a blood sample taken from a vein. - You may get a small bruise at the site. You can
lower the chance of bruising by keeping pressure on the site for several
minutes.
- In rare cases, the vein may become swollen after the blood
sample is taken. This problem is called phlebitis. A warm compress can be used
several times a day to treat this.
- Ongoing bleeding can be a
problem for people with bleeding disorders. Aspirin, warfarin (Coumadin), and
other blood-thinning medicines can make bleeding more likely. If you have
bleeding or clotting problems, or if you take blood-thinning medicine, tell
your doctor before your blood sample is taken.

A prostate-specific antigen (PSA) test
measures the amount of
in the blood. Normal values
may vary from lab to lab. NormalBecause normal PSA levels seem to increase
with age, age-specific ranges may be used. However, the use of age-specific
ranges is controversial, and some doctors prefer to use one range for all ages.
For this reason, it is important to discuss your test results with your doctor.
This table is a reference for white males. Results for black and Asian males
are slightly different. Total prostate-specific antigen (PSA)Men younger than
40: | Less than 2.5
| Less than 2.5
(SI units) |
|---|
Men age 40 to 50: | 0–2.5 ng/mL | 0–2.5 mcg/L |
|---|
Men age 51 to 60: | 0–3.5 ng/mL | 0–3.5 mcg/L |
|---|
Men age 61 to 70: | 0–4.5 ng/mL | 0–4.5 mcg/L |
|---|
Men over age 70: | 0–6.5 ng/mL | 0–6.5 mcg/L |
|---|
High values- PSA levels from 4 to 10 ng/mL: About 20% to
30% of men (20 to 30 men in 100) with PSA levels in this range may have
. A
and prostate
are needed to confirm a diagnosis of
cancer.
- PSA levels above 10 ng/mL: About 40% to 60% of men (40 to
60 men in 100) with PSA levels in this range may have prostate cancer. A
transrectal ultrasound (TRUS) and prostate biopsy are needed to confirm
cancer.
- High levels do not always mean prostate cancer is present.
PSA levels may be high if the prostate gland is enlarged () or inflamed
().
A follow-up test, percent free prostate-specific
antigen (free PSA), may be used to see if a prostate biopsy should be done to
check for cancer. Men with a low percentage of free PSA have a higher chance of
developing cancer as shown in the table below. Free prostate-specific antigen (fPSA)Percent free PSA | Probability of
cancer |
|---|
Greater than 25%: | 8% | 20%–25%: | 16% | 15%–20%: | 20% | 10%–15%: | 28% | 0–10%: | 56% | Low free PSA values (less than 15%) are more likely to
be caused by prostate cancer than high free PSA values. 
Factors that can interfere with
your test or the accuracy of the results include: - Recent sexual activity (ejaculation) or a
.
- Recent use of a tube () to drain urine.
- Recent
or
prostatitis.
- Large doses of medicines, such as cyclophosphamide
(Cytoxan, Neosar), diethylstilbestrol, and methotrexate for cancer
treatment.
- The medicine finasteride, such as Proscar or Avodart,
which is used to prevent further enlargement of the
in men with BPH.

- When combined with a
, the prostate-specific antigen
(PSA) test increases the chance of detecting prostate cancer. For more
information, see the medical test
Digital Rectal Examination (DRE).
- A PSA
level within the normal ranges does not mean that prostate cancer is not
present. Some men with prostate cancer have normal PSA levels.
- The American Cancer Society (ACS) advises doctors about when to
offer the PSA test and DRE:
- Offer these tests to men ages 50 and older
who are expected to live more than 10 years.
- Offer these tests to
men starting at age 45 if they are at high risk for prostate cancer. This group
includes African-American men and men who have a father, brother, or son who
was diagnosed with prostate cancer before age 65.
- Offer these tests
to men starting at age 40 if they are at an even higher risk for prostate
cancer. This group includes men who have several close relatives who had
prostate cancer at an early age.
- The
advises
doctors about when to test for prostate cancer:
- No testing is advised for men age 75 and
older.
- Before any tests, it is important for men younger than 75 to
talk with a doctor about the pros and cons of PSA testing.
- Men
younger than 75 who have long-term medical problems or who are expected to live
less than 10 years are not likely to benefit from testing.
- Some experts do not advise yearly testing. They
say the high rate of
and
results and the costs and risks of
further tests outweigh the benefits of yearly screening tests.
- Experts disagree about the type of testing that is appropriate if
the PSA level is high. The decision may depend on:
- Results of your digital rectal
exam.
- Results of any PSA tests you have had in the past. If your
PSA level gets higher in a short amount of time, follow-up testing may be
recommended.
- Your age and health.
- The costs and risks
of more tests and treatments.
- Other prostate tests are being evaluated to
determine how well they tell the difference between prostate cancer and benign
prostatic hypertrophy.
- The prostate-specific antigen density
(PSAD) test compares the PSA value to the size of the prostate gland. The size
of the prostate is measured using transrectal ultrasound
(TRUS).
- The PSA velocity test is a measure of how rapidly PSA
levels increase over time. PSA levels increase more rapidly in men with
prostate cancer and more slowly in men with prostate enlargement (benign
prostatic hypertrophy).
- Complexed prostate-specific antigen (cPSA) when used in
combination with a digital rectal exam can detect prostate cancer. The cPSA
test currently is not widely available.

Other Works ConsultedChernecky CC, Berger BJ, eds. (2004). Laboratory Tests and Diagnostic Procedures, 4th ed.
Philadelphia: Saunders. Fischbach FT, Dunning MB III, eds. (2004).
Manual of Laboratory and Diagnostic Tests, 7th ed.
Philadelphia: Lippincott Williams and Wilkins. Pagana KD, Pagana TJ (2006). Mosby’s Manual of Diagnostic and Laboratory Tests, 3rd ed. St. Louis:
Mosby.

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the . to help you make better health decisions. © 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Last modified on: 8 July 2009
|
|
|
|
|